194 related articles for article (PubMed ID: 22158303)
1. Intracranial implantation with subsequent 3D in vivo bioluminescent imaging of murine gliomas.
Abdelwahab MG; Sankar T; Preul MC; Scheck AC
J Vis Exp; 2011 Nov; (57):e3403. PubMed ID: 22158303
[TBL] [Abstract][Full Text] [Related]
2. Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells.
Clark AJ; Safaee M; Oh T; Ivan ME; Parimi V; Hashizume R; Ozawa T; James CD; Bloch O; Parsa AT
J Transl Med; 2014 Dec; 12():345. PubMed ID: 25464980
[TBL] [Abstract][Full Text] [Related]
3. Implantation of GL261 neurospheres into C57/BL6 mice: a more reliable syngeneic graft model for research on glioma-initiating cells.
Yi L; Zhou C; Wang B; Chen T; Xu M; Xu L; Feng H
Int J Oncol; 2013 Aug; 43(2):477-84. PubMed ID: 23708048
[TBL] [Abstract][Full Text] [Related]
4. Syngeneic Mouse Model of Glioblastoma: Intracranial Implantation of GL261 Cells.
Kaminska P; Cyranowski S; Pilanc P; Malik AR
Methods Mol Biol; 2024; 2746():135-146. PubMed ID: 38070086
[TBL] [Abstract][Full Text] [Related]
5. Bioluminescence and MR Imaging of the Safety and Efficacy of Vascular Disruption in Gliomas.
Folaron M; Seshadri M
Mol Imaging Biol; 2016 Dec; 18(6):860-869. PubMed ID: 27160251
[TBL] [Abstract][Full Text] [Related]
6. Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice.
Kim S; Zhang Y; Tang S; Qin C; Karelia D; Sharma A; Jiang C; Lu J
Prostate; 2019 Jun; 79(9):949-960. PubMed ID: 30958914
[TBL] [Abstract][Full Text] [Related]
7. Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.
Renner DN; Jin F; Litterman AJ; Balgeman AJ; Hanson LM; Gamez JD; Chae M; Carlson BL; Sarkaria JN; Parney IF; Ohlfest JR; Pirko I; Pavelko KD; Johnson AJ
PLoS One; 2015; 10(5):e0125565. PubMed ID: 25933216
[TBL] [Abstract][Full Text] [Related]
8. Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model.
Chae M; Peterson TE; Balgeman A; Chen S; Zhang L; Renner DN; Johnson AJ; Parney IF
Neuro Oncol; 2015 Jul; 17(7):978-91. PubMed ID: 25537019
[TBL] [Abstract][Full Text] [Related]
9. A therapeutic cancer vaccine against GL261 murine glioma.
Kindy MS; Yu J; Zhu H; Smith MT; Gattoni-Celli S
J Transl Med; 2016 Jan; 14():1. PubMed ID: 26727970
[TBL] [Abstract][Full Text] [Related]
10. Bioluminescence Imaging of an Immunocompetent Animal Model for Glioblastoma.
Clark AJ; Fakurnejad S; Ma Q; Hashizume R
J Vis Exp; 2016 Jan; (107):e53287. PubMed ID: 26863490
[TBL] [Abstract][Full Text] [Related]
11. GL261 luciferase-expressing cells elicit an anti-tumor immune response: an evaluation of murine glioma models.
Sanchez VE; Lynes JP; Walbridge S; Wang X; Edwards NA; Nwankwo AK; Sur HP; Dominah GA; Obungu A; Adamstein N; Dagur PK; Maric D; Munasinghe J; Heiss JD; Nduom EK
Sci Rep; 2020 Jul; 10(1):11003. PubMed ID: 32620877
[TBL] [Abstract][Full Text] [Related]
12. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis.
Jenkins DE; Oei Y; Hornig YS; Yu SF; Dusich J; Purchio T; Contag PR
Clin Exp Metastasis; 2003; 20(8):733-44. PubMed ID: 14713107
[TBL] [Abstract][Full Text] [Related]
13. Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps.
Kober C; Rohn S; Weibel S; Geissinger U; Chen NG; Szalay AA
J Transl Med; 2015 Jul; 13():216. PubMed ID: 26149494
[TBL] [Abstract][Full Text] [Related]
14. Efficacy against subcutaneous or intracranial murine GL261 gliomas in relation to the concentration of the vascular-disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), in the brain and plasma.
Yung R; Seyfoddin V; Guise C; Tijono S; McGregor A; Connor B; Ching LM
Cancer Chemother Pharmacol; 2014 Mar; 73(3):639-49. PubMed ID: 24477604
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic intracranial implantation and in vivo bioluminescent imaging of tumor xenografts in a mouse model system of glioblastoma multiforme.
Baumann BC; Dorsey JF; Benci JL; Joh DY; Kao GD
J Vis Exp; 2012 Sep; (67):. PubMed ID: 23051742
[TBL] [Abstract][Full Text] [Related]
16. Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma.
Pellegatta S; Valletta L; Corbetta C; Patanè M; Zucca I; Riccardi Sirtori F; Bruzzone MG; Fogliatto G; Isacchi A; Pollo B; Finocchiaro G
Acta Neuropathol Commun; 2015 Jan; 3():4. PubMed ID: 25849072
[TBL] [Abstract][Full Text] [Related]
17. Volume reconstruction techniques improve the correlation between histological and in vivo tumor volume measurements in mouse models of human gliomas.
Schmidt KF; Ziu M; Schmidt NO; Vaghasia P; Cargioli TG; Doshi S; Albert MS; Black PM; Carroll RS; Sun Y
J Neurooncol; 2004 Jul; 68(3):207-15. PubMed ID: 15332323
[TBL] [Abstract][Full Text] [Related]
18. Mathematical Analysis of Glioma Growth in a Murine Model.
Rutter EM; Stepien TL; Anderies BJ; Plasencia JD; Woolf EC; Scheck AC; Turner GH; Liu Q; Frakes D; Kodibagkar V; Kuang Y; Preul MC; Kostelich EJ
Sci Rep; 2017 May; 7(1):2508. PubMed ID: 28566701
[TBL] [Abstract][Full Text] [Related]
19. Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas.
Ni HT; Spellman SR; Jean WC; Hall WA; Low WC
J Neurooncol; 2001 Jan; 51(1):1-9. PubMed ID: 11349874
[TBL] [Abstract][Full Text] [Related]
20. Vaccination for experimental gliomas using GM-CSF-transduced glioma cells.
Herrlinger U; Kramm CM; Johnston KM; Louis DN; Finkelstein D; Reznikoff G; Dranoff G; Breakefield XO; Yu JS
Cancer Gene Ther; 1997; 4(6):345-52. PubMed ID: 9408604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
